Companies: 10,795·Total market cap: $144.5T
Aptose Biosciences Inc.

Aptose Biosciences Inc.

APTONASDAQHealthcare
$1.71
+$1.71(+100.00%)
Market Cap$4364655
P/E Ratio
52W High$43.191
52W Low$1.1
Overview

Aptose Biosciences Inc.(APTO)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · APTO · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-10.79apto eps ttm · apto earnings per shareEarnings history
PE Ratio (TTM)apto pe ratio ttm · apto price to earningsPE Ratio deep dive
Revenue (TTM)0.00apto revenue ttm · apto annual revenueFull revenue history
Dividend Yield不分红does apto pay dividends · apto dividend yieldDividend history
Shares Outstanding2.4Mapto shares outstanding · apto floatShares outstanding history
Next EarningsTBAapto earnings date · apto next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
aptose biosciences inc. revenue · apto revenue 2025
FY 2025Net Income$0.00▲ +100.00% YoY
202320242025
aptose biosciences inc. net income · apto profit 2025
FY 2025EPS$-10.41▼ 81.68% YoY
202320242025
apto eps · aptose biosciences inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: $5.5MEPS: $-10.79View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy11 位分析师is apto a buy · apto analyst rating
Strong Buy
0
Buy
10
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$1.71Current
$Avg Target
$High
apto price target · apto 12 month forecast

合计: 11 · 买入占比: 90.9%

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-50.86%
5Y-99.81%

关于 Aptose Biosciences Inc.

CEOWilliam G. Rice
IPO DateMar 16, 1992
Employees35
CountryCA
Websiteaptose.com

Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs wit…

what is aptose biosciences inc. · apto stock overview · aptose biosciences inc. company profile · who is aptose biosciences inc. ceo · apto NASDAQ · aptose biosciences inc. headquarters · aptose biosciences inc. business segments

关于股票概览与关键数据

Aptose Biosciences Inc.(APTO)是 Biotechnology 行业的 Healthcare 类公司,于 Mar 16, 1992 在 NASDAQ 上市。截至最近交易日,APTO 股价为 $1.71,市值约为 $4.4M。过去12个月累计回报 -50.86%,年初至今回报 +0.00%。

根据 11 位华尔街分析师,Aptose Biosciences Inc. 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 Aptose Biosciences Inc. 营收 —,净利润 —。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Aptose Biosciences Inc.(APTO)股价为 $1.71,在 NASDAQ 上市,52周区间为 $1.10 – $43.19。

APTO 最新股价APTO quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议